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Bone graftingAbstract Cleft lip and palate (CL/P) is a frequent congenital malformation that manifests in sev-
eral varieties including unilateral or bilateral and complete or incomplete. Alveolar cleft reconstruc-
tion remains controversial with regard to timing, graft materials, surgical techniques, and methods
of evaluation. Many studies have been conducted addressing these points to develop an acceptable
universal protocol for managing CL/P. The primary goal of alveolar cleft reconstruction in CL/P
patients is to provide a bony bridge at the cleft site that allows maxillary arch continuity, oronasal
ﬁstula repair, eruption of the permanent dentition into the newly formed bone, enhances nasal sym-
metry through providing alar base support, orthodontic movement and placement of osseointe-
grated implants when indicated. Other goals include improving speech, improvement of
periodontal conditions, establishing better oral hygiene, and limiting growth disturbances. In order
to rehabilitate oral function in CL/P patients alveolar bone grafting is necessary. Secondary bone
grafting is the most widely accepted method for treating alveolar clefts. Autogenous bone graft is
the primary source for reconstructing alveolar cleft defects and is currently the preferred grafting
material.
ª 2015 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
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Fifty years ago, the procedures for grafting bone were inconve-
nient, sporadically used, and lacked clear objectives. Alveolar
cleft reconstruction has been one of the most controversial sur-
gical procedures since it was the ﬁrst at the beginning of the
20th century. There were multiple philosophies and preferred
treatment modalities regarding each step in alveolar cleft man-
agement including grafting, the most appropriate age, the ideal
material, and whether adjunctive procedures such as
orthodontic expansion should be used before or after grafting
(Horswell and Henderson, 2003).
Cleft lip and/or palate (CL/P) is considered the most preva-
lent of the common human congenital craniofacial birth
defects. The approximate incidence ratio of CL/P has been
reported as 1:700 live births. In addition, CL/P is the second
most common congenital malformation following clubfoot
(Peter and Larsen, 2004).2. Pathogenesis
Cleft palate deformities occur when fusion of palatal shelves
fails to occur. These deformities are classiﬁed according to
the extent of the palatal involvement. Failure of the primary
and secondary palate to fuse leads to complete cleft palate,
in which the palatal shelves also fail to fuse. Complete palatal
clefts are typically associated with uni- or bilateral cleft lip
(Sadove et al., 2004). When the facial processes or palatine
shelves do not fuse, incomplete palatal clefts might occur
which could either affect the primary or secondary palate.
Consequently, the incomplete cleft palate can involve only
the posterior part of the soft palate, it may extend through
the hard palate to the incisive foramen, or it could be conﬁned
to the primary palate resulting in alveolar cleft (Jennifer et al.,
2007).
CL/P are more often unilateral than bilateral and more
common in males than in females. Unilateral defects on the left
side occur more often than on the right side. Cleft palate is
more common in females and most often associated with otherdevelopmental anomalies. Depending on the existence of asso-
ciated developmental anomalies, CL/P may be classiﬁed as
syndromic or isolated anomalies (Hagberg et al., 1998).
Isolated CL/P is a complex trait that usually results from a
combination of hereditary and environmental etiological fac-
tors. Previous research to identify the etiological genes and loci
responsible for CL/P has suggested that there may be any-
where from 3 to 14 genes involved (Cobourne, 2004). For iso-
lated CL/P, candidate genes and loci have been identiﬁed on
chromosomes 1, 2, 4, 6, 11, 14, 17and 19 (Blanton et al., 2004).
3. Etiology
Environmental factors that contribute to the etiology of facial
clefting disorders can be divided into four groups: drugs,
chemicals, maternal metabolic imbalances (as folic acid deﬁ-
ciency), and maternal infections. Maternal exposure to alcohol
and teratogenic medications such as retinoids, corticosteroids,
and anti-convulsants (phenytoin and valproic acid), and folic
acid deﬁciency during the periconceptional period can cause
clefting disorders. Consanguineous marriages, maternal dia-
betes, and obesity have also been linked to an increased risk
of orofacial clefts (Eppley et al., 2005).
The embryo undergoes rapid changes in shape and growth
between 4 and 8 weeks as the brain expands and the six bran-
chial arches are formed. The ﬁrst two branchial arches are pri-
marily responsible for the development of the face and the
cranium. The development of the face begins from the
ectomesenchyme of the neural crest, which forms ﬁve promi-
nences: the frontonasal process and two maxillary and
mandibular processes (one of each on a side) surrounding a
central depression. During the 5th and 6th weeks, the bilateral
maxillary processes derived from ﬁrst branchial arch fuse with
the medial nasal process to form the upper lip, alveolus, and
primary palate. The lateral nasal process forms the alar struc-
tures of the nose. The mandibular processes form the lower lip
and jaw. During the 8th week, the bilateral maxillary palatal
shelves ascend to an appropriate level above the tongue and
then fuse to each other and the primary palate to form the sec-
ondary palate (Fig. 1; Sperber et al., 2001).
Figure 1 Embryonic development of the face, 6th week Avery and Chiego (2006).
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proliferation, differentiation, adhesion, and apoptosis. The
processes of the neural crest cells are directed by molecular sig-
nals that are controlled by a group of genes that include the
transforming growth factor beta (TGF-b) super family, sonic
hedgehog (SHH), ﬁbroblast growth factors (FGFs), and bone
morphogenic proteins (BMPs). Failures or errors in any of
these intracellular mechanisms can disrupt the normal fusion
of the medial and lateral nasal processes and maxillary process
to cause orofacial clefts (Marazita and Mooney, 2004).
Every child born with a cleft lip or palate should be thor-
oughly assessed and evaluated by assessing their breathing
and looking for signs of airway obstruction; ability to feed;
nutritional intake; weight gain and growth; concomitant
anomalies (cardiac/renal/pulmonary/musculoskeletal); syn-
dromic associations that require genetic testing; and craniofa-
cial examination including head shape and circumference, ears,
eyes, nose, jaws, and oral cavity. Moreover, it is important to
evaluate the severity and type of cleft defect, the width of the
cleft, position of alveolar segments and premaxilla, nasal
deformity, the need for presurgical orthopedics and type of
appliance necessary, and to prepare the child and parents for
surgical repair of cleft lip (Bagheri et al., 2012).
4. Classiﬁcation
Classiﬁcation schemes for cleft palate are usually anatomically
based. This may include complete or incomplete, unilateral or
bilateral, a submucous cleft, and biﬁd uvula. The primary goal
of cleft palate repair is to restore the function of the palate and
aid the development of normal speech. Maxillary alveolar
clefts can prevent normal eruption of the permanent dentition
and can therefore inhibit facial growth and symmetry.
Alveolar bone grafting in the mixed dentition phase allows
the canine teeth to migrate and erupt through the cancellous
bone. Success rates with bone grafting are generally reported
at 90–95% (Bagheri et al., 2012).5. Rationale for alveolar bone grafting
The restoration of jaw function and morphology in CL/P
patients is critically important and requires reconstruction of
the maxillary alveolar clefts depending on osteogenic potential
and bone regeneration in osseous defects (Kawata et al., 2004).
The primary goal of maxillary alveolar cleft reconstruction
in CL/P patients is to build bone in the cleft area which in turn
allows: removes the oronasal ﬁstula, establishes maxillary arch
continuity, limits growth disturbance and movement of the
permanent dentition into the grafted bone, enhances nasal
symmetry, orthodontic movement and insertion of dental
implants, speech improvement, oral hygiene maintenance,
and improves periodontal health (Peter and Larsen, 2004).
Adequate preparation at the site of the alveolar cleft defect
enables it to receive an appropriate quantity of autogenous
bone graft, which followed by healthy mucogingival ﬂaps ade-
quately covering the graft, results in a functional and anatom-
ically united maxilla. Deferring this procedure until the
secondary mixed dentition stage when maxillary transverse
growth is almost complete will limit the hazards of growth dis-
turbances (Horswell and Henderson, 2003; Trindade et al.,
2005; Le and Woo, 2009). Moreover, bone grafting achieves
a stable dental arch that will minimize inward collapse of the
alveolar segments and provide subsequent improvement in
orthodontic stability (Peter and Larsen, 2004). Alveolar cleft
reconstruction provides a bone matrix to support permanent
dentition movement once orthodontics are completed.
Providing space for lateral incisor and/or permanent canine
eruption into stabilized alveolar bone maintains bony support
of the teeth adjacent to the alveolar cleft (Hynes and Earley,
2003; Peter and Larsen, 2004).
Oronasal ﬁstulas in CL/P patients vary in size and conse-
quently, offer several challenges for surgical management.
Oronasal ﬁstulas allow air leakage to the anterior nasal cavity
during speech, affect oral hygiene and periodontal health, and
are unpleasant to the patient especially during eating and
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deﬁciency and premaxillary instability in bilateral clefts.
Hence, addressing oronasal ﬁstula may beneﬁt both hygiene
and speech by improving nasal emission and nasality
(Horswell and Henderson, 2003; Peter and Larsen, 2004).
Nasal deformity associated with unilateral CL/P is associ-
ated with social stigma and can be a psychological burden to
the patient. Bone support to the alar base is one of the most
important goals of alveolar cleft reconstruction (Honma
et al., 1999). Alveolar bone reconstruction in conjunction with
nasal correction can be performed later in childhood. To
improve nasal projection, the alveolar cleft defect can be
reconstructed with autogenous bone and a small stent ﬁtted
at the anterior nasal spine simultaneously (Horswell and
Henderson, 2003).
Absent or malformed lateral incisors are generally consid-
ered to be an issue for a permanent prosthetic or occlusal prob-
lem even when the alveolar cleft reconstruction is successful.
This problem has been successfully overcome recently by
inserting an endosseous implant (Le and Woo, 2009; Ronchi
et al., 1995). In addition, placing a dental implant in the
grafted cleft area maintains the grafted bone in patients who
underwent secondary bone grafting for alveolar cleft repair.
This is attributed to bone remodeling in response to implant
loading (Takahashi et al., 2008).
An oronasal ﬁstula can adversely affect speech due to air
leakage through the ﬁstula. The oronasal ﬁstula is most likely
to adversely affect speech when it is 4.5 mm2 or larger.
However, grafting the alveolar cleft and closing the oronasal
ﬁstula have been associated with apparent improvement in
tone and the reduction of hypernasality (Bureau et al., 2001).
Alveolar cleft grafting also improves oral hygiene and pre-
serves dentition, as CL/P patients have some periodontal
struggles due to oronasal ﬁstula, inadequate oral hygiene,
and long-term orthodontic therapy (Bra¨gger et al., 1985;
Peter and Larsen, 2004).
5.1. Pre- versus post-surgical orthodontics
Most authors prefer presurgical expansion, citing easier expan-
sion due to less resistance, improved access to the cleft for clos-
ing the nasal ﬂoor, better postoperative hygiene, and less
chance of reopening the oronasal ﬁstula (Ochs, 1996; Peter
and Larsen, 2004). Unilateral or bilateral CL/P patients may
require orthodontic treatment to minimize the deformity of
the anterior maxillary projection using orthopedic devices dur-
ing infancy. Orthodontics, with or without orthopedic treat-
ment, might also be required during the deciduous dentition
stage. In addition, during both the mixed and permanent den-
tition phases, orthodontic treatment is frequently required
either alone or in association with orthognathic surgery
(Machos, 1996).
Orthodontic treatment should be started at least 6 months
before bone graft placement using ﬁxed appliances in the max-
illary dental arch. Developing a favorable arch form by
expanding the anterior and/or posterior maxillary dental arch
is considered the main treatment goal at this stage. While par-
tially or completely eliminating the misalignment of the inci-
sors and cross bites are the corner stone of orthodontic
treatment, improvement of dental function and esthetics
should also be the required objectives. Orthodontists shouldavoid moving teeth roots into the cleft defect. However, the
incisor root could be moved distally into a cleft, if pre-
angulated brackets are used, but the subsequent prognosis is
poor. Keeping the incisor roots invested in bone at the presur-
gical stage is preferable; the correct tooth angulation can be
achieved after successful bone grafting (Machos, 1996).
Advocates of expansion following grafting cite the advan-
tages that bone consolidation is improved when the graft is
placed under a dynamic load during healing, a smaller soft tis-
sue defect to close, less difﬁculty procuring an adequate volume
of bone, and a narrower defect, which will regenerate bone
more quickly (Peter and Larsen, 2004; da Silva et al., 2009).
Both approaches have been used in conjunction with autoge-
nous grafting in the mixed dentition stage with success. Not
only is it controversial whether expansion should be under-
taken pre- versus post-surgery, there are also two schools of
thought regarding orthodontic movement of the erupted per-
manent teeth adjacent to the cleft site. Previous reports have
directly correlated the success of grafting with the presence of
adequate bone on the distal surface of the central incisor preop-
eratively (Enemark et al., 2001; Peter and Larsen, 2004).
5.2. Timing of the graft
Review of the literature is inconclusive regarding the most
favorable time for alveolar bone grafting (Freihofer et al.,
1993). There are two possible approaches regarding the time
of alveolar bone reconstruction: (1) primary bone grafting sur-
gery during infancy and (2) secondary bone grafting during the
mixed dentition stage (Eichhorn et al., 2009). The staging of
alveolar bone reconstruction is based chronologically on the
patient’s age classiﬁed as follows: (1) Primary stage- patients
younger than 2 years old, (2) Early secondary stage- patients
from 2 to 5 years of age, (3) Mixed secondary stage- patients
from 5 to 16 years of age, and (4) Late secondary- patients
older than 16 years of age (Eppley, 1996).
5.2.1. Primary grafting
Primary bone grafting involves alveolar cleft reconstruction in
association with soft tissue repair to the lip during infancy.
Early alveolar repair was described in the 1950s by (Nordin
and Johansen) who presented concomitant autogenous bone
grafting of the alveolar bone performed with soft tissue repair
to the lip and palate. This concept gained popularity because it
simultaneously addressed both soft tissue and bony deﬁcit
repair and created the possibility for harmonious facial growth
and development (Ochs, 1996). Bone grafting at an early age
stabilizes the arch and allows the deciduous teeth to erupt into
the newly formed bone (Eichhorn et al., 2009). The primary
goal of alveolar cleft repair performed before palatal closure
is to prevent the limiting effects of surgical palate closure on
early midfacial development, which decreases the need for sub-
sequent arch expansion during orthodontic treatment
(Rosenstein, 2003).
Although performing an iliac crest bone graft before canine
eruption is generally considered the gold standard for alveolar
cleft reconstruction, previous studies have concluded that
tooth eruption has never occurred in synthetic bone substi-
tutes. Lazarou et al. (1997) demonstrated for the ﬁrst time that
teeth can erupt through calcium-based bone substitutes that
turn into a normal functioning bone in the alveolar ridge.
Alveolar cleft reconstruction 7Calcium substitutes provide substantial advantages over other
biomaterials and autologous bone grafts for primary alveolar
cleft grafting.
Not all patients are suitable for primary grafting, those that
are should meet the following criteria: (1) complete palatal
cleft (patients with intact part of hard palate are not candidates
for primary grafting) and (2) the alveolar segments should be
properly aligned (end-to-end) orthodontically before grafting,
because the presence of a gap between the maxillary segments
will create tension on the ﬂap over the grafted bone and
increase the risk of postoperative wound dehiscence, graft
exposure, and subsequent failure of the graft (Eppley, 1996).
Bone grafts used for primary grafting include the onlay rib
graft and calvarial bone graft (Eichhorn et al., 2009).
5.2.2. Secondary bone grafting
Secondary alveolar bone grafting is the most appealing and
popular method to treat alveolar clefts. It is usually suggested
when half of the canine root is almost complete. At this stage
of root development, the tooth shows accelerated and active
eruption. Moreover, most of the mid-facial growth and devel-
opment is completed. This corresponds to a chronological age
of 9–12 years (Hynes and Earley, 2003; Ochs, 1996). The pri-
mary goals of secondary alveolar bone reconstruction are to
provide a mature bony matrix that supports canine movement
and the formation of a stable united dental arch. The
orthodontic movement of teeth facilitates complete dental
rehabilitation and prosthodontic reconstruction, oronasal ﬁs-
tula repair, and provides bony support for the lip and nose
(Baqain et al., 2009; Hynes and Earley, 2003).
5.3. Types of bone grafting
The ideal bone graft material for alveolar cleft reconstruction
remains as controversial as the timing issue for osseous repair
in CL/P management. Various sources of bone graft material
have been suggested in the literature including autogenic, allo-
genic, xenogenic, and alloplastic grafts. The outcomes
achieved with different graft sources have been extensively
compared in the literature (Horswell and Henderson, 2003;
Ochs, 1996). Identifying the optimal donor site for alveolar
cleft reconstruction has been a dilemma for many years.
Several factors inﬂuence the choice of donor site for harvesting
the bone graft for cleft reconstruction including the expertise
and preference of the surgeon, the available bone volume,
and the morbidity associated with harvesting from a particular
site (Rawashdeh and Telfah, 2008).
Bone grafts harvested from autogenous donor sites are used
extensively in oral and maxillofacial surgery to rebuild small
and large bony defects. Multiple donor sites have been sug-
gested in the literature including the anterior and posterior
ilium, proximal tibia, rib, mandibular symphysis, and calvarial
bone. However, every site has potential complications; there-
fore, the optimal donor site remains open to debate (Baqain
et al., 2009; Eichhorn et al., 2009). Previous research concluded
that the corticocancellous blocks used for grafting facial bony
defects in an onlay fashion can maintain their volume when a
membranous bone source is used rather than an endochondral
bone (Rawashdeh and Telfah, 2008).
In contrast, other scholars (Ozaki and Buchman, 1998;
Ozaki et al., 1999) have compared the ability of inlay bonegrafts from membranous bones (mandibles) to maintain their
volumes in the craniofacial skeleton to the endochondral cor-
tical and cancellous bone harvested from iliac crests of rabbits.
The results indicated that in contrast to the data for onlay
bone grafts that resorbed over time, inlay bone grafts were
maintained and increased in volume over time. Furthermore,
cancellous bone of endochondral origin had the greatest vol-
ume. They concluded that the dynamics of cancellous inlay
bone grafts were different from onlay cortical bone grafts.
The alveolar process defect in CL/P patients is considered
to be a marginal defect in the continuity of the pyriform aper-
ture and the alveolus. Thus, alveolar cleft reconstruction is
assumed to be inlay grafting between the osseous segments,
rather than an onlay graft on the maxilla (Rawashdeh and
Telfah, 2008).
An autogenous bone graft harvested from the anterior or
the posterior iliac crest is considered the optimal source of
autogenous bone for alveolar cleft reconstruction and hence
it is termed the ‘‘gold standard bone graft.’’ Moreover, there
is a consensus that iliac bone is the standardized graft to which
different types of alveolar bone grafts should be compared.
The anterior iliac crest has the advantage of providing a large
quantity of cancellous bone and easy surgical access.
Furthermore, it has great osteogenic potential especially in
the early phase following grafting due to abundant pluripotent
osteogenic precursor cells. Cancellous bone is considered supe-
rior to corticocancellous bone, because it is relatively easy to
harvest, reduces the operative time, and contains a greater
number of osteogenic precursor cells. In addition, cancellous
bone from the ilium placed in the alveolar cleft has a pre-
dictable outcome and a high success rate. However, reﬂection
of musculo-periosteal ﬂaps during surgical exposure of the iliac
crest can result in signiﬁcant post-operative morbidities includ-
ing hematoma, pain, discomfort, delayed ambulation, and pro-
longed hospitalization (Baqain et al., 2009; Rawashdeh and
Telfah, 2008; Swan and Goodacre, 2006).
Previous reports have suggested that the calvarial bone
graft has the advantage of being superior in the esthetic out-
come due to inconspicuous scar formation. In addition, lack
of functional deformity, a convenient surgical ﬁeld, and the
volume of bone that can be harvested make the calvarial bone
graft a good choice for postoperative morbidity (Keese and
Schmelzle, 1995; Strong and Moulthrop, 2000). However, cal-
varial bone harvesting carries the risks of wound infection,
minimal cancellous bone, intracranial complications, and thin
bone (Strong and Moulthrop, 2000; Vahtsevanos et al., 2007).
Harvesting from the calvarial donor site might also reduce the
strength of the skull. Consequently, different donor sites are
recommended for those who have a high probability of multi-
ple head injuries such as some athletes (Rawashdeh and
Telfah, 2008).
Tibial bone graft has been advocated widely in orthopedic
surgery. Consequently, it has gained popularity as autogenous
grafting material for jaw reconstruction, orthognathic surgery,
cleft repair, and preprosthetic surgery (Amin Kalaaji et al.,
2001; Rawashdeh and Telfah, 2008). The tibia is preferred
because it is easy to harvest, has minimal bleeding, allows
rapid ambulation, and has a rich cancellous bone marrow
depository (Horswell and Henderson, 2003; Hughes and
Revington, 2002). However; the proximal tibia has the disad-
vantage in children of growing epiphyseal cartilage and being
limited in size. Consequently, the surgical operating ﬁeld
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possible injury to the growth center. Some long-term follow-
up studies have concluded that potential injury to proximal
tibial growth center has not been reported in CL/P patients
(Besly and Booth, 1999; Rawashdeh and Telfah, 2008).
Mandibular symphysis bone graft was ﬁrst introduced by
Bosker and van Dijk (1980) for secondary alveolar cleft recon-
struction with good results. The symphysial bone graft har-
vested from the mandible has advantages in that both the
surgical ﬁelds for the donor and recipient sites are conﬁned to
the oral cavity, reduced operative time, minimal postoperative
complications and morbidity, and no extra oral scars.
Moreover, the symphysial bone is thought to show superior inte-
gration into the cleft defect since both the donor bone and recip-
ient bed have the same intramembranous origin. Nevertheless,
the main disadvantage of symphysial bone graft is the limited
quantity available thus, it is considered less suitable for large uni-
lateral or bilateral cleft reconstruction (Ba¨hr and Coulon, 1996;
Enemark et al., 2001; Rawashdeh and Telfah, 2008).
The rib is the second most frequently used autogenous graft
for alveolar cleft defect repair. Together with the calvarial
bone, the ribs are thought to be a practical donor site for auto-
genic bone for primary alveolar grafting (Eichhorn et al., 2009;
Eppley, 1996; Horswell and Henderson, 2003). Incomplete
graft integration into the alveolar bone, a lack of bone reser-
voir, and teeth being unable to erupt are the primary disadvan-
tages reported in the literature for rib grafts. In addition,
inadequate alar base support, the possibility of a pneumotho-
rax, and persistent postoperative pain are frequently reported
disadvantages. Ribs do not have signiﬁcant advantages over
bone harvested from the ilium for alveolar cleft reconstruction
that would warrant a preference for using rib grafts in the
mixed-dentition stage (Eppley, 1996; Horswell and
Henderson, 2003).
(Allografts) allogeneic bone has been suggested for alveolar
cleft reconstruction because it overcomes the disadvantages of
autogenous bone grafts. It has the advantages of limiting sur-
gery time, providing an abundant quantity of bone, and elim-
inates donor site morbidity. Allografts offer both osteo-
induction and osteo-conduction properties. Bone morpho-
genetic proteins (BMPs) provide osteoinduction, and are
released in response to osteoclastic activity to stimulate bio-
incorporation of the graft. The calciﬁed collagen structure pre-
sents osteo-conduction properties forming a scaffold that facil-
itates bone deposition (Filho et al., 2013).
It is not recommended to use bone substitutes (alloplastic
grafts), such as hydroxylapatite, for alveolar cleft reconstruc-
tion in growing children with unerupted teeth near the cleft
defect. Alloplastic grafts should be offered for alveolar ridge
augmentation in adult patients who do not plan on future
insertion of endosteal implants. Research data and clinical
experience regarding the use of xenografts and bioceramics
in alveolar cleft reconstruction are highly controversial and
there is insufﬁcient evidence in the literature. Therefore, their
use in alveolar cleft reconstruction is not recommended
(Ochs, 1996).
Recently, the use of alloplastic grafts and xenografts has
gained much popularity in sinus grafting and alveolar grafting
for dental implants due to their availability, although they are
expensive; but there is not enough data about their use alone
without autogenous bone for alveolar cleft reconstruction
(Kasabah et al., 2002; Tadjoedin et al., 2003).Another possible type of bone graft utilized a 1:1 mix of
decalciﬁed freeze-dried bone and a granular bioactive glass
graft material to rebuild the alveolar cleft defect. The results
of the case report showed proper cleft repair as well as better
periodontal conditions of the teeth around the cleft area.
Teeth were successfully moved into the reconstructed bone
composed of demineralized freeze-dried bone and bioactive
glass (Yılmaz et al., 2000).
Skoog (1965) ﬁrst introduced the term ‘‘boneless grafting,’’
which was later modiﬁed by others to primary gingivoperios-
teoplasty. He hypothesized that closure of the healthy mucope-
riosteum over the alveolar cleft site in conjunction with
primary lip repair would create a favorable environment for
potential osteogenic effects that would in turn allow bony
bridging to cross the alveolar cleft defect. (Brusati and
Mannucci, 1992; Horswell and Henderson, 2003; Rawashdeh
and Telfah, 2008).
In 1980 Ralph Millard pioneered the use of a small gin-
givoperiosteal ﬂap for alveolar cleft repair at the age of
5 months. The ﬂap was elevated from both the alveolar cleft
margins and then rotated over in the form of a tunnel to close
the alveolar defect. This technique had the advantage of main-
taining good periosteal vascularity. However, the disadvantage
of the procedure is that it can be applied to limited defects
only. In cases of wide alveolar clefts, Millard suggested the
use of active orthopedic devices at 3 months of age pre-
surgically. The orthopedic device was known as the ‘Latham
device’ (Henkel and Gundlach, 1997).
Previous studies have reported that alveolar clefts treated
with primary cleft repair that ﬁlled with adequate bone sup-
ported erupting teeth. Bone formation after primary cleft
reconstruction using gingivoperiosteoplasty has been reported
to occur in 50–100% of cases (Brusati and Mannucci, 1992;
Horswell and Henderson, 2003; Rawashdeh and Telfah,
2008). While bone grafting is not a common pediatric proce-
dure in some medical centers, other medical centers, for exam-
ple the Oslo group, take the position that almost all alveolar
clefts even if treated with gingivoperiosteoplasty, will eventu-
ally require bone grafting due to deﬁcient bone quantity.
Medical centers that perform primary gingivoperiosteoplasty
question whether infants who have undergone primary bone
grafting may have received unnecessary grafts. (Horswell and
Henderson, 2003).
5.4. New grafting materials
The TGF-b family includes multifunctional bone morpho-
genetic proteins (BMPs) that are the only molecules that signal
to induce new bone formation at either orthotopical or hetero-
topical sites. In addition, their osteoinduction power suggests
that they may have clinical beneﬁts as novel alternatives to tra-
ditional bone grafts (Kirker-Head, 2000).
Tissue engineering has been used to provide new alterna-
tives for bone reconstruction. Tissue engineering uses three
dimensional bone-like scaffolds that are loaded with bone cells
that are planted in the bony defect for bone reconstruction.
The scaffolds used can be of natural or synthetic origin.
Tissue engineering has clinical applications that have pro-
gressed from the laboratory to the bedside. The clinical appli-
cations for tissue engineering include augmenting alveolar
ridge defects and ﬁlling limited sized defects in the jaw bone
(Pradel et al., 2008; Schmelzeisen et al., 2003).
Alveolar cleft reconstruction 9A combination of autologous mesenchymal stem cells and
platelets rich in plasma was ﬁrst introduced by Hibi et al.
(2006) for alveolar cleft reconstruction, which provided ade-
quate bone bridging at the cleft site. Furthermore, the perma-
nent lateral incisor and canine teeth had moved into the newly
formed bone. Behnia et al. (2009) utilized mesenchymal stem
cells carried on a scaffold that combined demineralized bone
and calcium sulfate for alveolar cleft reconstruction. The
results suggested that the amount of bone formation was inad-
equate and indicated that the conventional bone substitute was
a suitable scaffold for mesenchymal stem cells for alveolar
bone regeneration.
Guided bone regeneration (GBR) is a surgical technique
that has broad appeal to improve both the quality and the
quantity of the newly formed osseous structures in localized
areas of alveolar ridge discontinuity defects. It also enhances
the osteoinduction power of different grafting materials that
are extensively used for bone reconstruction (Sanchez et al.,
2003).
Autologous platelet concentrates contain storage pools of
growth factors, which are assumed to promote tissue repair.
The growth factors retained in the platelet concentrates include
platelet derived growth factor (PDGF), tumor growth factor
beta (TGF-beta), vascular endothelial growth factor
(VEGF), and other cytokines. For these reasons, treatment
with autologous platelet concentrates in clinical situations that
require rapid healing and augmented tissue regeneration have
gained popularity and shown some positive outcomes. Their
application in the form of ﬁbrin meshwork that gives rise to
support and adhesion will result in conﬁnement of growth fac-
tors secretion to a limited area (Anitua et al., 2004).
Platelet-rich plasma (PRP) is the ﬁrst generation of platelet
concentrates that has been utilized widely to accelerate both
soft and hard tissue healing. Isolation of PRP is the ﬁrst step
in preparing PRP, then calcium chloride and bovine thrombin
were added to accelerate gel formation. Sanchez et al. (2003)
studied the potential hazards that accompany the use of
PRP. They concluded that the generation of antibodies to fac-
tors V, XI, and thrombin might be attributable to the use of
bovine thrombin, and life-threatening coagulopathies could
occur (Sunitha and Munirathnam, 2008).
Platelet-rich ﬁbrin (PRF) was initially introduced by
Choukroun et al. (2006). PRF was considered as the second-
generation platelet concentrate. It has been shown to be supe-
rior to the ﬁrst generation traditionally prepared PRP. These
advantages include the absence of biochemical handling of
the blood and simpliﬁed preparation (Sunitha and
Munirathnam, 2008). Furthermore, it demonstrated that
bovine thrombin added during preparation of PRP may have
toxic effect on body cells. On the other hand, PRF preparation
is a mechanical and non-biochemical procedure that does not
add thrombin. In contrast to PRP, which rapidly releases
growth factors just before cell outgrowth from the surrounding
tissue, the ﬁbrin meshwork formed within PRF minimizes pro-
teolysis and the rapid destruction of growth factors. Therefore,
the activity of the growth factors can be retained for a longer
time due to controllable, long-term growth factor release.
Levels of released TGF-b1 and PDGF-AB are markedly
increased and peak at day 14, then decrease slightly (Ling
et al., 2009).
Prepared PRF comes as a gel like material that can be used
in conjunction with bone substitutes. The combination offersseveral advantages including enhanced wound repair,
improved bone maturation and growth, stable grafting, ade-
quate wound sealing and hemostasis, and improved handling
of the graft materials. Moreover, PRF can be pressed into a
membrane and used for guided bone regeneration. Clinical
studies have emphasized that combining growth factor rich
PRF and bone grafts could enhance bone quality and quantity
(Sunitha and Munirathnam, 2008).
5.5. Evaluation of alveolar cleft bone grafting
Numerous studies have been done to compare the complex
methods used for analyzing bone grafts. The analytical tech-
niques attempted to trace the position height and width of
bone close to the roots of the teeth is at the cleft site. Inter-
and intra-examiner variability affects the reliability of these
analytical methods for use in clinical management (Hynes
and Earley, 2003). In the past standard periapical radiographs
were obtained in order to evaluate the reconstructed alveolar
cleft, and evaluated using the Bergland scale and Chelsae scale
(Trindade et al., 2005).
For many years, bone graft success and measurement relied
on what was considered the gold standard method. In
Bergland grading system, a four point scale was used to clas-
sify and evaluate each graft depending on the coronal level
of the interdental bone graft compared to the normal bone
(Hynes and Earley, 2003; Kindelan and Roberts-Harry,
1999; Nightingale et al., 2003; Trindade et al., 2005). One
drawback of the Bergland scale was that the graft was com-
pared only at the interdental level using the normal bone level
as a reference. To overcome this disadvantage, the Chelsea
scale was developed to assess the level of the bone within the
cleft compared to the full length of the root surfaces of the
teeth next to the cleft and cleft midline at eight sites.
Another four point scale developed by Kindelan compared
the percentage of bony inﬁll at the cleft site to the pre surgical
occlusal radiographs and post-operative records (Nightingale
et al., 2003).
Conventional periapical, occlusal, and orthopantogram
radiographs that are used for alveolar cleft assessment are
not reliable due to distortion of the images at the cleft area.
In addition, the two dimensional evaluation does not provide
a reliable anatomical index, which creates subsequent difﬁcul-
ties for accurate three dimensional evaluation of the cleft area.
Therefore, CT scan should be used to overcome these draw-
backs in evaluating the alveolar cleft (Nightingale et al.,
2003). Recently, studies have assessed reconstruction of the
alveolar defects using CT scan and specialized software to
measure the volume of the defect and determine the amount
needed for grafting. Moreover, CT scans can also be used to
evaluate the amount of newly formed bone in the defect and
provides accurate results based on 3D analysis (Honma
et al.,1999; Tai et al., 2000).
Between 1998 and 1999 cone-beam (CB) systems were
introduced for oral & maxillofacial imaging, and numerous
CB devices are commercially available. Currently, CB systems
have been extensively indicated for several maxillofacial sur-
gery imaging (Robert et al., 2007). CB scanners offer several
advantages over conventional CT scanners including a limited
radiation dose that is approximately 15-times less than conven-
tional CT scanners, minimal scanning time (10–70 s), and high
quality, high resolution diagnostic imaging (Scarfe et al.,
10 S.A. Seifeldin2006). The available CB machines are capable of matching the
geometric range of the conventional CT scanners in terms of
accuracy. It has also been demonstrated that accurate volu-
metric measurements can be achieved with the data acquired
from CBCT devices. Halation artifacts of the image intensiﬁer
produce potential impairment of the segmentation quality in
objects located at the periphery of the imaging ﬁeld should
be taken into consideration (Robert et al., 2007).
6. Summary
In terms of promoting growth and restoration of function,
secondary bone grafts of the alveolar cleft are the most
widely accepted timing for surgical reconstruction.
Autogenous bone grafts are still considered the gold standard
for alveolar cleft reconstruction with most reliable, pre-
dictable, and best outcomes despite the emergence of novel
composite grafting materials with powerful osteoinductive
capabilities.
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